Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia

Authors: Fuentes-Antrás, Jesús, de Luna, Alicia, López de Sá, Alfonso, Ocaña, Alberto, García-Sáenz, José Ángel, Moreno, Fernando

Source: Breast. 54:160-163

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100117686695.0x000001&indx=1&recIds=ETOCvdc_100117686695.0x000001

Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)

Authors: González-Santiago, Santiago, Saura, Cristina, Ciruelos, Eva, Alonso, José Luis, de la Morena, Pilar, Santisteban Eslava, Marta, Gallegos Sancho, Maria Isabel, de Luna, Alicia, Dalmau, Elsa, Servitja, Sonia, Ruiz Borrego, Manuel, Chacón, José Ignacio

Source: Breast cancer research and treatment. 184(2):469-479

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183643461.0x000001&indx=1&recIds=ETOCvdc_100183643461.0x000001

Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort.

Authors: Sánchez-Bayona, Rodrigo, Lopez de Sa, Alfonso, Jerez Gilarranz, Yolanda, Sanchez de Torre, Ana, Alva, Manuel, Echavarria, Isabel, Moreno, Fernando, Tolosa, Pablo, Herrero Lopez, Blanca, de Luna, Alicia, Lema, Laura, Gamez Casado, Salvador, Madariaga, Ainhoa, López-Tarruella, Sara, Manso, Luis, Bueno-Muiño, Coralia, Garcia-Saenz, Jose A., Ciruelos, Eva, Martin, Miguel

Source: Breast Cancer Research & Treatment; Aug2024, Vol. 206 Issue 3, p551-559, 9p

Caracterización de las aguas residuales generadas en la producción de conjugados monovalentes en el Instituto Finlay de Vacuna.

Alternate Title: Characterization of the wasteswater generated in the production of conjugated monovalent at the Finlay Vaccine Institute.

Authors: Perojo-Bellido de Luna, Alicia Margarita¹ aperojo@finlay.edu.cu, Aguilera-Corrales, Yuri², Villar-Aneiros, Annette¹, de la Caridad Avilés-Aguilera, Yudisleydis¹

Source: Revista VacciMonitor (Vacunología y Temas Afines). 2022, Vol. 31 Issue 2, p60-67. 8p.

Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.

Authors: Fuentes-Antrás, Jesús, Martínez-Rodríguez, Ana, Guevara-Hoyer, Kissy, López-Cade, Igor, Lorca, Víctor, Pascual, Alejandro, de Luna, Alicia, Ramírez-Ruda, Carmen, Swindell, Jennifer, Flores, Paloma, Lluch, Ana, Cescon, David W., Pérez-Segura, Pedro, Ocaña, Alberto, Jones, Frederick, Moreno, Fernando, García-Barberán, Vanesa, García-Sáenz, José Ángel

Source: International Journal of Molecular Sciences; Jul2023, Vol. 24 Issue 14, p11419, 20p

Subject Terms: METASTATIC breast cancer, AROMATASE inhibitors, CANCER patients, CIRCULATING tumor DNA, SOMATIC mutation, BREAST

This result is not displayed to guests.
Login for full access.